🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase I/II trial studies the safety and effectiveness of lenalidomide ...
Status
Completed
Location
University of Chicago
Start Date
2013-10-17
Trial ID
NCT01838434
Treatments Being Tested
The primary objectives of this study is to evaluate the safety and efficacy...
Status
Completed
Location
Stanford Cancer Center
Start Date
2011-02
Trial ID
NCT01306643
Treatments Being Tested
The primary objective of this study is to evaluate the effects of idelalisi...
Status
Terminated
Location
Sansum Clinic
Start Date
2015-04-21
Trial ID
NCT01980875
Treatments Being Tested
This phase IB trial studies the feasibility of using a functional laborator...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-13
Trial ID
NCT02779283
Treatments Being Tested
This study will evaluate the long-term safety of pirtobrutinib in participa...
Status
Recruiting
Location
Mitchell Cancer Institute
Start Date
2026-03-09
Trial ID
NCT07218341
Treatments Being Tested
The primary objective of this study is to provide idelalisib to participant...
Status
Terminated
Location
Multiple Locations
Start Date
2016-05-04
Trial ID
NCT02739360
Treatments Being Tested
The primary objective of this study is to evaluate the progression-free sur...
Status
Terminated
Location
St. Jude Heritage Healthcare Virginia K. Crosson Cancer Center
Start Date
2014-02-05
Trial ID
NCT01980888
Treatments Being Tested
The primary objective will be to assess the overall response rate and to ev...
Status
Completed
Location
St. Jude Medical Center
Start Date
2011-03-18
Trial ID
NCT01282424
Treatments Being Tested
The purpose of this study is to determine the dose that can be safely given...
Status
Completed
Location
Stanford Cancer Center
Start Date
2008-06
Trial ID
NCT00710528
Treatments Being Tested
This research study is evaluating a drug called idelalisib (formerly known ...
Status
Terminated
Location
Dana Farber Cancer Institute
Start Date
2015-10
Trial ID
NCT02439138
Treatments Being Tested